Patterson Companies, Inc. (NASDAQ:PDCO) Shares Bought by American Century Companies Inc.

American Century Companies Inc. increased its position in shares of Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 24.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,711,030 shares of the company's stock after purchasing an additional 527,054 shares during the period. American Century Companies Inc. owned 3.07% of Patterson Companies worth $83,662,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of PDCO. Values First Advisors Inc. boosted its holdings in Patterson Companies by 2.9% in the fourth quarter. Values First Advisors Inc. now owns 11,961 shares of the company's stock valued at $369,000 after purchasing an additional 337 shares in the last quarter. Anchor Investment Management LLC boosted its stake in Patterson Companies by 20.5% in the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock valued at $51,000 after acquiring an additional 400 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Patterson Companies by 18.0% during the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock worth $84,000 after purchasing an additional 417 shares during the last quarter. Spire Wealth Management lifted its holdings in shares of Patterson Companies by 11.2% in the 4th quarter. Spire Wealth Management now owns 4,160 shares of the company's stock valued at $128,000 after purchasing an additional 419 shares during the last quarter. Finally, US Bancorp DE boosted its position in shares of Patterson Companies by 1.6% in the 4th quarter. US Bancorp DE now owns 32,767 shares of the company's stock valued at $1,011,000 after purchasing an additional 514 shares during the period. 85.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have commented on PDCO shares. Morgan Stanley upped their price objective on Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Leerink Partnrs cut Patterson Companies from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Robert W. Baird increased their price target on Patterson Companies from $25.00 to $31.00 and gave the stock a "neutral" rating in a report on Thursday, December 12th. StockNews.com assumed coverage on shares of Patterson Companies in a research note on Thursday. They issued a "hold" rating on the stock. Finally, Mizuho began coverage on shares of Patterson Companies in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $23.00 target price for the company. Eleven investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $26.57.

Patterson Companies Stock Down 0.1 %

Shares of NASDAQ:PDCO traded down $0.04 during mid-day trading on Friday, hitting $31.21. 837,579 shares of the company traded hands, compared to its average volume of 1,056,420. The firm has a market cap of $2.76 billion, a P/E ratio of 18.25, a PEG ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a 52-week low of $19.45 and a 52-week high of $31.79. The firm's 50 day simple moving average is $31.07 and its 200 day simple moving average is $26.44. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37.

Patterson Companies Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.